- Home
- Publications
- Publication Search
- Publication Details
Title
Regulation of IL-22BP in psoriasis
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-03-29
DOI
10.1038/s41598-018-23510-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Limited Presence of IL-22 Binding Protein, a Natural IL-22 Inhibitor, Strengthens Psoriatic Skin Inflammation
- (2017) Jérôme C. Martin et al. JOURNAL OF IMMUNOLOGY
- Of men and mice: analysing the action of an established drug using tumour necrosis factor-α-deficient mice in the imiquimod psoriasis model
- (2016) F. Kurschus BRITISH JOURNAL OF DERMATOLOGY
- A pathogenic role for T cell–derived IL-22BP in inflammatory bowel disease
- (2016) Penelope Pelczar et al. SCIENCE
- IL-22, cell regeneration and autoimmunity
- (2015) Enayat Nikoopour et al. CYTOKINE
- IL-22BP is produced by eosinophils in human gut and blocks IL-22 protective actions during colitis
- (2015) J C Martin et al. Mucosal Immunology
- IL-6 Regulates Neutrophil Microabscess Formation in IL-17A-Driven Psoriasiform Lesions
- (2013) Andrew L. Croxford et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Subclinical CNS Inflammation as Response to a Myelin Antigen in Humanized Mice
- (2013) Morad Zayoud et al. Journal of Neuroimmune Pharmacology
- Interleukin-22 binding protein (IL-22BP) is constitutively expressed by a subset of conventional dendritic cells and is strongly induced by retinoic acid
- (2013) J CJ Martin et al. Mucosal Immunology
- An Alternative Pathway of Imiquimod-Induced Psoriasis-Like Skin Inflammation in the Absence of Interleukin-17 Receptor A Signaling
- (2012) Khalifa El Malki et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine
- (2012) Samuel Huber et al. NATURE
- IL-22-Induced Regulatory CD11b+ APCs Suppress Experimental Autoimmune Uveitis
- (2011) Y. Ke et al. JOURNAL OF IMMUNOLOGY
- IL-22 Is Required for Imiquimod-Induced Psoriasiform Skin Inflammation in Mice
- (2011) A. B. Van Belle et al. JOURNAL OF IMMUNOLOGY
- Diclofenac: an update on its mechanism of action and safety profile
- (2010) Tong J. Gan CURRENT MEDICAL RESEARCH AND OPINION
- Biology of interleukin-22
- (2010) Kerstin Wolk et al. Seminars in Immunopathology
- Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
- (2009) L. van der Fits et al. JOURNAL OF IMMUNOLOGY
- IL-22 Produced by Human NK Cells Inhibits Growth of Mycobacterium tuberculosis by Enhancing Phagolysosomal Fusion
- (2009) R. Dhiman et al. JOURNAL OF IMMUNOLOGY
- The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis
- (2009) Antonella Di Cesare et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Crystal structure of the IL-22/IL-22R1 complex and its implications for the IL-22 signaling mechanism
- (2008) Lucas Bleicher et al. FEBS LETTERS
- IL-22 is required for Th17 cell–mediated pathology in a mouse model of psoriasis-like skin inflammation
- (2008) Hak-Ling Ma et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis
- (2008) Ken Sugimoto et al. JOURNAL OF CLINICAL INVESTIGATION
- Cyclooxygenases: structural and functional insights
- (2008) Carol A. Rouzer et al. JOURNAL OF LIPID RESEARCH
- Structure of IL-22 Bound to Its High-Affinity IL-22R1 Chain
- (2008) Brandi C. Jones et al. STRUCTURE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started